Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Muggeo

Showing results (91-100 of 181) with videos related to

Pageof 19
Sort By:
Diabetes Care|June 17, 2000
Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetesG Targher, L Bertolini, L Zenari, et al.
Diabetologia|December 7, 2007
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patientsG Targher, L Bertolini, S Rodella, et al.
Diabetes Care|September 10, 1999
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck StudyE Bonora, S Kiechl, J Willeit, et al.
Journal of Internal Medicine|May 1, 1996
The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individualsG Targher, J C Seidell, M Tonoli, et al.
Diabetes Care|November 28, 2001
Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic controlE Bonora, F Calcaterra, S Lombardi, et al.
Hormone Research|January 1, 1982
Autoantibodies to the insulin receptor and insulin-resistant diabetesE Van Obberghen, C Grunfeld, L C Harrison, et al.
Diabetologia|February 7, 2001
Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck StudyE Bonora, S Kiechl, F Oberhollenzer, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 27, 2003
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck StudyE Bonora, S Kiechl, J Willeit, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolismA C Pessina, L Ciccariello, F Perrone, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1978
The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemiaJ S Flier, R S Bar, M Muggeo, et al.
Pageof 19

Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Diabetes Care|June 17, 2000
Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetesG Targher, L Bertolini, L Zenari, et al.
Diabetologia|December 7, 2007
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patientsG Targher, L Bertolini, S Rodella, et al.
Diabetes Care|September 10, 1999
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck StudyE Bonora, S Kiechl, J Willeit, et al.
Journal of Internal Medicine|May 1, 1996
The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individualsG Targher, J C Seidell, M Tonoli, et al.
Diabetes Care|November 28, 2001
Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic controlE Bonora, F Calcaterra, S Lombardi, et al.
Hormone Research|January 1, 1982
Autoantibodies to the insulin receptor and insulin-resistant diabetesE Van Obberghen, C Grunfeld, L C Harrison, et al.
Diabetologia|February 7, 2001
Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck StudyE Bonora, S Kiechl, F Oberhollenzer, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 27, 2003
Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck StudyE Bonora, S Kiechl, J Willeit, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolismA C Pessina, L Ciccariello, F Perrone, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1978
The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemiaJ S Flier, R S Bar, M Muggeo, et al.
Pageof 19